GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Pretax Margin %

MedMira (MedMira) Pretax Margin % : -396.40% (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is MedMira Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. MedMira's Pre-Tax Income for the three months ended in Jan. 2024 was $-0.44 Mil. MedMira's Revenue for the three months ended in Jan. 2024 was $0.11 Mil. Therefore, MedMira's pretax margin for the quarter that ended in Jan. 2024 was -396.40%.

The historical rank and industry rank for MedMira's Pretax Margin % or its related term are showing as below:

MMIRF' s Pretax Margin % Range Over the Past 10 Years
Min: -716.67   Med: -225.53   Max: -31.53
Current: -716.67


MMIRF's Pretax Margin % is ranked worse than
69.55% of 1018 companies
in the Biotechnology industry
Industry Median: -154.275 vs MMIRF: -716.67

MedMira Pretax Margin % Historical Data

The historical data trend for MedMira's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Pretax Margin % Chart

MedMira Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -399.75 -222.47 -31.56 -192.39 -617.68

MedMira Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -288.19 -554.43 -2,803.85 -661.63 -396.40

Competitive Comparison of MedMira's Pretax Margin %

For the Biotechnology subindustry, MedMira's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMira's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where MedMira's Pretax Margin % falls into.



MedMira Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

MedMira's Pretax Margin for the fiscal year that ended in Jul. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-2.026/0.328
=-617.68 %

MedMira's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.44/0.111
=-396.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMira  (OTCPK:MMIRF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


MedMira Pretax Margin % Related Terms

Thank you for viewing the detailed overview of MedMira's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMira (MedMira) Business Description

Traded in Other Exchanges
Address
155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

MedMira (MedMira) Headlines

From GuruFocus

MedMira Receives CE Mark for Its VYRA(TM) COVID-19 Antigen Test

By ACCESSWIRE ACCESSWIRE 10-14-2022

Progress Update on MedMira's COVID-19 Product Family

By GlobeNewswire GlobeNewswire 01-30-2021

MedMira Announces Product Update

By GlobeNewswire GlobeNewswire 12-31-2020

MedMira Reports Second Quarter Results

By GlobeNewswire GlobeNewswire 03-30-2018

Management Cease Trade Order Update

By GlobeNewswire GlobeNewswire 12-26-2018

MedMira Reports Third Quarter Results

By GlobeNewswire GlobeNewswire 06-30-2018